Sponsor:
Adicet Therapeutics
Code:
NCT06375993
Conditions
Lupus Nephritis
Autoimmune Diseases
Systemic Sclerosis (SSc)
Systemic Lupus Erythematosus (SLE)
ANCA-Associated Vasculitis (AAV)
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
ADI-001
Fludarabine
Cyclophosphamide
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-02-13. This information was provided to ClinicalTrials.gov by Adicet Therapeutics on 2025-08-12.